0000896262-22-000011.txt : 20220222
0000896262-22-000011.hdr.sgml : 20220222
20220222210040
ACCESSION NUMBER: 0000896262-22-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220217
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kusserow Paul B. K.
CENTRAL INDEX KEY: 0001456688
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 22660390
MAIL ADDRESS:
STREET 1: 780 SAN YSIDRO ROAD
CITY: SANTA BARBARA
STATE: CA
ZIP: 93108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
wf-form4_164558162362374.xml
FORM 4
X0306
4
2022-02-17
0
0000896262
AMEDISYS INC
AMED
0001456688
Kusserow Paul B. K.
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
1
1
0
0
See Remarks
Common Stock
2022-02-17
4
M
0
49092
0
A
398663
D
Common Stock
2022-02-17
4
F
0
9659
143.25
D
389004
D
Common Stock
2022-02-17
4
F
0
9659
143.25
D
379345
D
Common Stock
83764
I
By Trust
Common Stock
621
I
Through 401(k) Plan
Restricted Stock Units
2022-02-17
4
M
0
73638
0
D
Common Stock
73638.0
0
D
On January 2, 2019, the Reporting Person was awarded 73,638 performance-based Restricted Stock Units ("RSUs") with vesting based on certification of achievement of identified performance goals for each of fiscal years 2019 through 2021 (1/3 of the RSUs vest, if at all, based on achievement of the 2019 performance goal; 1/3 of the RSUs vest, if at all, based on achievement of the 2020 performance goal; and 1/3 of the RSUs vest, if at all, based on achievement of the 2021 performance goal). The Compensation Committee of the Issuer has certified achievement of the 2019 and 2020 performance measures, but the 2021 performance measure was not satisfied, thereby resulting in the Reporting Person earning 49,092 shares of common stock, which are reported in Table I.
The information in this report is based on a plan statement dated as of December 31, 2021.
CEO and Chairman of the Board
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2022-02-22